CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma

Huifang Zhou,1,2 Libo Su,3 Chao Liu,3 Baosheng Li,2 Hui Li,4 Ying Xie,3 Dianxing Sun1,2 1Graduate School of Hebei Medical University, Hebei Medical University, Shijiazhuang, People’s Republic of China; 2The Liver Disease Center of PLA, The 980th Hospital of PLA Joint Logistics Support Forc...

Full description

Bibliographic Details
Main Authors: Zhou H, Su L, Liu C, Li B, Li H, Xie Y, Sun D
Format: Article
Language:English
Published: Dove Medical Press 2019-09-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/cthrc1-may-serve-as-a-prognostic-biomarker-for-hepatocellular-carcinom-peer-reviewed-article-OTT
id doaj-85ef8a5961864a81a9e300b82526ffae
record_format Article
spelling doaj-85ef8a5961864a81a9e300b82526ffae2020-11-25T01:18:10ZengDove Medical PressOncoTargets and Therapy1178-69302019-09-01Volume 127823783148773CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular CarcinomaZhou HSu LLiu CLi BLi HXie YSun DHuifang Zhou,1,2 Libo Su,3 Chao Liu,3 Baosheng Li,2 Hui Li,4 Ying Xie,3 Dianxing Sun1,2 1Graduate School of Hebei Medical University, Hebei Medical University, Shijiazhuang, People’s Republic of China; 2The Liver Disease Center of PLA, The 980th Hospital of PLA Joint Logistics Support Force, Shijiazhuang, People’s Republic of China; 3Hebei Key Laboratory of Laboratory Animal Science, Hebei Medical University, Shijiazhuang, People’s Republic of China; 4Department of Pathology, The 980th Hospital of PLA Joint Logistics Support Force, Shijiazhuang, People’s Republic of ChinaCorrespondence: Dianxing SunThe Liver Disease Center of PLA, The 980th Hospital of PLA Joint Logistics Support Force, 398 West Zhongshan Road, Shijiazhuang 050082, People’s Republic of ChinaTel +86 311 8797 8434Fax +86 311 8797 8434Email sundianxing@hotmail.comYing XieHebei Key Lab of Laboratory Animal Science, Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang 050017, People’s Republic of ChinaTel +86 311 8626 6844Fax +86 311 8626 6844Email 15930141651@163.comBackground: Hepatocellular carcinoma is a common malignant cancer and the second most common cause of cancer-related deaths worldwide. Collagen triple helix repeat containing 1 (CTHRC1) has been increasingly reported to be involved in tumorigenesis and/or tumor progression. However, limited data are available regarding the role of CTHRC1 in hepatocellular carcinoma.Methods: Paraffin-embedded specimens from a total of 29 patients with HCC were collected in our study. The expression of CTHRC1 in hepatocellular carcinoma was evaluated using immunohistochemistry and bioinformatics analysis. Furthermore, Spearman analysis was performed to identify factors of correlation between CTHRC1 and clinicopathological features. Survival curves for hepatocellular carcinoma were produced using the Kaplan-Meier method and the log rank test.Results: In this study, we confirmed that CTHRC1 is highly expressed in tissues and hepatoma cell lines. The statistical analysis revealed that the levels of CTHRC1 were significantly correlated with cirrhosis (P=0.024), tumor size (P=0.006), vascular invasion (P<0.001), TNM stage (P<0.001), and BCLC stage (P<0.001). High expression of CTHRC1 in hepatocellular carcinoma tissues is significantly associated with poor survival.Conclusion: CTHRC1 may serve as a prognostic biomarker for hepatocellular carcinoma.Keywords: hepatocellular carcinoma, CTHRC1, biomarker, bioinformaticshttps://www.dovepress.com/cthrc1-may-serve-as-a-prognostic-biomarker-for-hepatocellular-carcinom-peer-reviewed-article-OTThepatocellular carcinomaCTHRC1biomarkerbioinformatics.
collection DOAJ
language English
format Article
sources DOAJ
author Zhou H
Su L
Liu C
Li B
Li H
Xie Y
Sun D
spellingShingle Zhou H
Su L
Liu C
Li B
Li H
Xie Y
Sun D
CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
OncoTargets and Therapy
hepatocellular carcinoma
CTHRC1
biomarker
bioinformatics.
author_facet Zhou H
Su L
Liu C
Li B
Li H
Xie Y
Sun D
author_sort Zhou H
title CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
title_short CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
title_full CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
title_fullStr CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
title_full_unstemmed CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
title_sort cthrc1 may serve as a prognostic biomarker for hepatocellular carcinoma
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2019-09-01
description Huifang Zhou,1,2 Libo Su,3 Chao Liu,3 Baosheng Li,2 Hui Li,4 Ying Xie,3 Dianxing Sun1,2 1Graduate School of Hebei Medical University, Hebei Medical University, Shijiazhuang, People’s Republic of China; 2The Liver Disease Center of PLA, The 980th Hospital of PLA Joint Logistics Support Force, Shijiazhuang, People’s Republic of China; 3Hebei Key Laboratory of Laboratory Animal Science, Hebei Medical University, Shijiazhuang, People’s Republic of China; 4Department of Pathology, The 980th Hospital of PLA Joint Logistics Support Force, Shijiazhuang, People’s Republic of ChinaCorrespondence: Dianxing SunThe Liver Disease Center of PLA, The 980th Hospital of PLA Joint Logistics Support Force, 398 West Zhongshan Road, Shijiazhuang 050082, People’s Republic of ChinaTel +86 311 8797 8434Fax +86 311 8797 8434Email sundianxing@hotmail.comYing XieHebei Key Lab of Laboratory Animal Science, Hebei Medical University, 361 East Zhongshan Road, Shijiazhuang 050017, People’s Republic of ChinaTel +86 311 8626 6844Fax +86 311 8626 6844Email 15930141651@163.comBackground: Hepatocellular carcinoma is a common malignant cancer and the second most common cause of cancer-related deaths worldwide. Collagen triple helix repeat containing 1 (CTHRC1) has been increasingly reported to be involved in tumorigenesis and/or tumor progression. However, limited data are available regarding the role of CTHRC1 in hepatocellular carcinoma.Methods: Paraffin-embedded specimens from a total of 29 patients with HCC were collected in our study. The expression of CTHRC1 in hepatocellular carcinoma was evaluated using immunohistochemistry and bioinformatics analysis. Furthermore, Spearman analysis was performed to identify factors of correlation between CTHRC1 and clinicopathological features. Survival curves for hepatocellular carcinoma were produced using the Kaplan-Meier method and the log rank test.Results: In this study, we confirmed that CTHRC1 is highly expressed in tissues and hepatoma cell lines. The statistical analysis revealed that the levels of CTHRC1 were significantly correlated with cirrhosis (P=0.024), tumor size (P=0.006), vascular invasion (P<0.001), TNM stage (P<0.001), and BCLC stage (P<0.001). High expression of CTHRC1 in hepatocellular carcinoma tissues is significantly associated with poor survival.Conclusion: CTHRC1 may serve as a prognostic biomarker for hepatocellular carcinoma.Keywords: hepatocellular carcinoma, CTHRC1, biomarker, bioinformatics
topic hepatocellular carcinoma
CTHRC1
biomarker
bioinformatics.
url https://www.dovepress.com/cthrc1-may-serve-as-a-prognostic-biomarker-for-hepatocellular-carcinom-peer-reviewed-article-OTT
work_keys_str_mv AT zhouh cthrc1mayserveasaprognosticbiomarkerforhepatocellularcarcinoma
AT sul cthrc1mayserveasaprognosticbiomarkerforhepatocellularcarcinoma
AT liuc cthrc1mayserveasaprognosticbiomarkerforhepatocellularcarcinoma
AT lib cthrc1mayserveasaprognosticbiomarkerforhepatocellularcarcinoma
AT lih cthrc1mayserveasaprognosticbiomarkerforhepatocellularcarcinoma
AT xiey cthrc1mayserveasaprognosticbiomarkerforhepatocellularcarcinoma
AT sund cthrc1mayserveasaprognosticbiomarkerforhepatocellularcarcinoma
_version_ 1725143352303681536